MARKET

ALEC

ALEC

Alector
NASDAQ
1.930
-0.010
-0.52%
After Hours: 1.930 0 0.00% 16:10 07/07 EDT
OPEN
1.970
PREV CLOSE
1.940
HIGH
1.970
LOW
1.855
VOLUME
416.16K
TURNOVER
--
52 WEEK HIGH
3.400
52 WEEK LOW
1.090
MARKET CAP
214.28M
P/E (TTM)
-1.6228
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ALEC last week (0629-0703)?
Weekly Report · 1d ago
Rani Therapeutics Appoints Nicholas Maestas CFO Following Sanford Departure
NASDAQ · 06/30 05:44
Weekly Report: what happened at ALEC last week (0622-0626)?
Weekly Report · 06/29 09:14
Weekly Report: what happened at ALEC last week (0615-0619)?
Weekly Report · 06/22 09:16
Alector Shareholders Back Directors, Auditor and Executive Pay
TipRanks · 06/17 21:33
Alector shareholders ratify Ernst & Young as auditor for fiscal 2026
PUBT · 06/17 20:06
Weekly Report: what happened at ALEC last week (0608-0612)?
Weekly Report · 06/15 09:16
This Insider Has Just Sold Shares In Alector
Simply Wall St · 06/09 10:49
More
About ALEC
Alector, Inc. is a clinical-stage biotechnology company. The Company is focused on developing therapies to counteract the devastating progression of neurodegenerative diseases. It also develops alector brain carrier (ABC), a proprietary blood-brain barrier platform, which is applied to its next-generation product candidates and research pipeline. Its research and drug discovery platform leverages human genetic datasets, advanced tools in bioinformatics and imaging, and insights in neurodegeneration. Its clinical development portfolio includes latozinemab (AL001) and AL101/GSK4527226, while its preclinical and research pipeline candidates include ADP037-ABC, ADP050-ABC, ADP056, and ADP063-ABC/ADP064-ABC. Its first product candidate, latozinemab, is a human recombinant monoclonal antibody that increases the levels of progranulin (PGRN) in the brains of FTD-GRN patients. The AL101/GSK4527226, is a human recombinant monoclonal antibody designed to elevate PGRN levels in the brain.

Webull offers Alector Inc stock information, including NASDAQ: ALEC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ALEC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ALEC stock methods without spending real money on the virtual paper trading platform.